How Not to Be an ATM for Your CRO with Outsourcing Checks and Balances, Upcoming Webinar Hosted by Xtalks
In this free webinar, attendees will gain insights into customizing service provider solutions to meet both clinical operations' and financial needs and setting up expectations and processes to get more outsourcing transparency. The featured speakers will discuss the benefits of using a functional service provider vs all-in-one partners as well as best practices for managing the right partner choice for your company.
TORONTO, Oct. 9, 2020 /PRNewswire-PRWeb/ -- As a clinical trial sponsor, the overall value and expertise that can be gained in outsourcing services for clinical studies is clear. However, many partnerships don't last long because they fail to deliver study milestones and quality work. When a CRO's weaknesses overshadow their strengths, the partnership may be entirely terminated, rather than just replacing the service(s) that failed to deliver.
Small to midsize companies usually have limited finances and a shorter timeline to run a clinical program vs. Big Pharma. Any delay resulting from a partner's failure to deliver on time has a greater impact on smaller Sponsors. Small to midsize companies trying to get innovative therapies to the clinic with just the right amount of money, should consider starting with functional CROs that have proven experience to get through all phases of clinical trials.
Using a large or full service CRO does not mean less work or fewer functional team members, CRO's study teams are usually located all over the world depending on their responsibility or the third party the CRO outsourced. How is this any different than using several specialized CROs to support study services? The same communication and protocol training is required for both options. However, with the functional CRO route, the sponsor will own the contract with the CROs and will have full transparency into the costs, milestones achieved, study delays and first-hand knowledge of the study impact regarding any protocol changes or database migrations.
Join Erin O'Boyle, Senior Director Clinical Operations at Rezolute, Inc. and Stephen Boccardo, SVP Business Development, and Commercial Strategy, Quartesian in a live webinar on Wednesday, October 21, 2020 at 1pm EDT.
For more information or to register for this event, visit How Not to Be an ATM for Your CRO with Outsourcing Checks and Balances.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
SOURCE Xtalks
Share this article